UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Infosys
INFY
|
+$767M |
| 2 |
Amazon
AMZN
|
+$288M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$287M |
| 4 |
NVIDIA
NVDA
|
+$259M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$347M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$316M |
| 3 |
Citigroup
C
|
+$269M |
| 4 |
Charter Communications
CHTR
|
+$229M |
| 5 |
NetEase
NTES
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.35% |
| 2 | Consumer Discretionary | 13.14% |
| 3 | Financials | 12.19% |
| 4 | Healthcare | 12.04% |
| 5 | Communication Services | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
United Parks & Resorts
PRKS
$2.12B
| $3.12M | ﹤0.01% |
62,848
-202
| -0.3% | -$8K |
|
1502
SPX Corp
SPXC
$10.8B
| $3.12M | ﹤0.01% |
53,511
-1,190
| -2% | -$67.7K |
|
|
CMD
1503
DELISTED
Cantel Medical Corporation
CMD
| $3.11M | ﹤0.01% |
38,928
-3,383
| -8% | -$264K |
|
|
FOLD
1504
DELISTED
Amicus Therapeutics
FOLD
| $3.11M | ﹤0.01% |
314,549
+26,457
| +9% | +$410K |
|
1505
Diodes
DIOD
$4.84B
| $3.1M | ﹤0.01% |
38,814
-842
| -2% | -$66.6K |
|
1506
Commault Systems
CVLT
$5.61B
| $3.1M | ﹤0.01% |
48,009
-841
| -2% | -$53.4K |
|
1507
Kratos Defense & Security Solutions
KTOS
$11.4B
| $3.1M | ﹤0.01% |
113,485
-10,427
| -8% | -$292K |
|
1508
News Corp Class B
NWS
$17.5B
| $3.09M | ﹤0.01% |
131,864
-6,367
| -5% | -$138K |
|
1509
Coherus Oncology
CHRS
$196M
| $3.09M | ﹤0.01% |
211,449
-2,042,457
| -91% | -$34.7M |
|
1510
World Kinect Corp
WKC
$1.86B
| $3.09M | ﹤0.01% |
87,713
-110,090
| -56% | -$3.74M |
|
1511
Brady Corp
BRC
$4.57B
| $3.09M | ﹤0.01% |
57,731
-1,006
| -2% | -$52.6K |
|
1512
Brookfield Infrastructure
BIPC
$4.85B
| $3.08M | ﹤0.01% |
+60,324
| New | +$2.72M |
|
1513
Schneider National
SNDR
$6.25B
| $3.07M | ﹤0.01% |
123,064
-9,063
| -7% | -$212K |
|
1514
Minerals Technologies
MTX
$2.34B
| $3.07M | ﹤0.01% |
40,776
-3,380
| -8% | -$239K |
|
1515
TriNet
TNET
$3.14B
| $3.07M | ﹤0.01% |
39,339
+1,579
| +4% | +$127K |
|
1516
Aaon
AAON
$7.77B
| $3.05M | ﹤0.01% |
65,309
-1,594
| -2% | -$78.2K |
|
|
ACH
1517
Accendra Health
ACH
$214M
| $3.05M | ﹤0.01% |
81,022
+1,822
| +2% | +$57K |
|
1518
Integer Holdings
ITGR
$4.26B
| $3.04M | ﹤0.01% |
33,045
-201
| -0.6% | -$17K |
|
|
CCXI
1519
DELISTED
ChemoCentryx, Inc.
CCXI
| $3.04M | ﹤0.01% |
59,340
+1,094
| +2% | +$65.8K |
|
|
FSP
1520
Franklin Street Properties
FSP
$46.8M
| $3.03M | ﹤0.01% |
556,227
+30,618
| +6% | +$153K |
|
|
MAXR
1521
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $3.03M | ﹤0.01% |
80,075
-15,772
| -16% | -$702K |
|
1522
Kontoor Brands
KTB
$4.26B
| $3.02M | ﹤0.01% |
62,300
-4,438
| -7% | -$198K |
|
|
AGNT
1523
AGNT Inc
AGNT
$734M
| $3.01M | ﹤0.01% |
66,065
-2,951
| -4% | -$157K |
|
|
RCM
1524
DELISTED
R1 RCM Inc. Common Stock
RCM
| $3.01M | ﹤0.01% |
121,822
-3,947
| -3% | -$104K |
|
1525
Columbia Banking Systems
COLB
$8.84B
| $2.99M | ﹤0.01% |
69,333
-1,844
| -3% | -$80.4K |
|
Similar funds
UBS AM's Q1 2021 Portfolio in Review
As of Q1 2021, UBS AM held 2,645 positions worth $226B, up 6% from $213B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q1 2021: portfolio turnover was 4.9%. UBS AM opened 86 new positions and exited 44, leaving the 2,645-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Financials.
- UBS AM's largest Q1 2021 buy was Seagen Inc. Common Stock: 966,114 shares worth $134M.
- UBS AM added most to Infosys in Q1 2021, an estimated $767M increase.
- UBS AM's biggest Q1 2021 reduction was Alibaba, cutting an estimated $347M.
- UBS AM fully exited Lumen in Q1 2021, selling an estimated $45.5M.
- UBS AM's ten largest holdings make up 22% of its $226B portfolio in Q1 2021.
- UBS AM opened 86 new positions and closed 44 in Q1 2021.
- UBS AM's portfolio value rose 6% quarter-over-quarter to $226B.
Based on UBS AM's 13F filing for Q1 2021, filed 14 May 2021.